Celebrating Leadership in Behavioral Health: Dr. McGrath's Impact

Health Enterprise Partners Recognizes Dr. Patrick McGrath
Patrick McGrath, PhD, Chief Clinical Officer of NOCD, honored for leadership and commitment to clinical innovation.
Health Enterprise Partners (HEP) proudly announces today the recognition of Dr. Patrick McGrath, Chief Clinical Officer of NOCD, as the distinguished recipient of their second annual RISE Above Award. This award celebrates individuals who embody resilience, integrity, straightforwardness, and dedication to education in the field of behavioral health - principles that resonate deeply within the HEP community.
Understanding the RISE Above Award
The RISE Above Award is a tribute to the values demonstrated by Steve Filchock during his long-standing association with HEP. According to Dave Tamburri, Managing Partner at HEP, the award highlights individuals who exhibit qualities essential for fostering advancements in mental health treatment. "Dr. McGrath exemplifies these attributes through his visionary leadership and unwavering commitment to enhancing treatment for obsessive-compulsive disorder (OCD), resulting in significant improvements for patients and clinicians alike," he shared.
Dr. McGrath's Lifelong Commitment
With over 25 years dedicated to pioneering evidence-based treatments for OCD, Dr. McGrath stands as a recognized leader in his field. He has played a pivotal role in making Exposure and Response Prevention (ERP) therapy - the gold-standard for treating OCD - widely accessible. Through his leadership at NOCD, Dr. McGrath has developed a robust specialized clinical network, mentoring countless therapists along the way, ensuring that effective treatment reaches those in need.
Reflections on Career and Recognition
Reflecting on the honor of receiving the RISE Above Award, Steve Filchock commends Dr. McGrath’s exceptional career, emphasizing the real-world impact it has had on many individuals. He pointed out that Dr. McGrath's achievements align seamlessly with the core values of HEP and the spirit of the award itself.
In his heartfelt response, Dr. McGrath expressed, "The most fulfilling aspect of my career lies in guiding individuals towards the lives they aspire to lead, free from the limitations imposed by OCD. Receiving this recognition for my work is deeply meaningful to me, especially when I think of all my NOCD colleagues who tirelessly strive to provide compassionate and effective care to those affected by OCD."
Supporting Causes Beyond Recognition
In light of Dr. McGrath's accomplishments, HEP has chosen to support the I AM ALS - PUSH FOR PROGRESS initiative. This program advocates for the ongoing authorization of the Act for ALS, which was signed into law recently, ensuring that critical resources continue to be available for those impacted by ALS. The Filchock family will generously match this contribution, reiterating their dedication to the cause.
About Health Enterprise Partners
Health Enterprise Partners is committed to providing expansion capital to innovative companies in the healthcare space, focusing on healthcare services and information technology. The firm's strategic investments are enhanced by a unique and comprehensive network of hospital systems and health plans. HEP prioritizes companies that successfully improve patient experiences, broaden access to care, and manage healthcare costs effectively.
About NOCD
As a leading behavioral health specialist, NOCD is recognized globally for delivering millions of specialized OCD therapy sessions. The organization services patients using a network of licensed therapists skilled in ERP therapy. NOCD not only partners with a variety of stakeholders within the healthcare system, including clinicians and insurance plans, but also works diligently to ensure high-quality care is accessible to all patients requiring treatment for OCD.
Frequently Asked Questions
What is the RISE Above Award?
The RISE Above Award is given by Health Enterprise Partners to acknowledge individuals who exemplify resilience, integrity, and dedication in the field of behavioral health.
Who is the recipient of the 2025 RISE Above Award?
Patrick McGrath, PhD, Chief Clinical Officer of NOCD, is the recipient of the 2025 RISE Above Award, recognized for his contributions to OCD treatment.
What is the significance of Dr. McGrath's work?
Dr. McGrath has significantly advanced the accessibility of evidence-based treatments for OCD, positively impacting countless patients and therapists.
How does HEP support healthcare initiatives?
Health Enterprise Partners supports healthcare initiatives by investing in innovative companies focused on improving patient experiences and access to care.
What does NOCD specialize in?
NOCD specializes in providing comprehensive outpatient therapy for OCD, offering a network of therapists skilled in Evidence-based Exposure and Response Prevention therapy.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.